|Bid||672.13 x 1100|
|Ask||819.87 x 800|
|Day's Range||745.97 - 764.70|
|52 Week Range||507.22 - 832.70|
|Beta (5Y Monthly)||0.89|
|PE Ratio (TTM)||5.59|
|Earnings Date||Oct 27, 2021 - Nov 01, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||856.25|
Bio-Rad (BIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Investors are optimistic about Bio-Rad (BIO) on solid international market performance and raised 2021 guidance.
In this article, we will take a look at the 11 best genomic stocks to buy now. If you want to skip our detailed analysis of these stocks, go directly to 5 Best Genomic Stocks to Buy Now. Genomics is a branch of biology that studies the structure, function, evolution, mapping, and editing of genomes, […]